Growth Metrics

Resmed (RMD) Long-Term Deferred Tax (2016 - 2025)

Resmed's Long-Term Deferred Tax history spans 16 years, with the latest figure at $285.9 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax rose 36.51% year-over-year to $285.9 million; the TTM value through Dec 2025 reached $285.9 million, up 36.51%, while the annual FY2025 figure was $253.1 million, 24.34% up from the prior year.
  • Long-Term Deferred Tax reached $285.9 million in Q4 2025 per RMD's latest filing, up from $275.9 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $285.9 million in Q4 2025 to a low of $49.9 million in Q1 2021.
  • Average Long-Term Deferred Tax over 5 years is $147.8 million, with a median of $135.6 million recorded in 2023.
  • Peak YoY movement for Long-Term Deferred Tax: soared 94.58% in 2021, then decreased 0.2% in 2022.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $74.7 million in 2021, then rose by 14.88% to $85.8 million in 2022, then soared by 81.8% to $156.0 million in 2023, then surged by 34.3% to $209.4 million in 2024, then soared by 36.51% to $285.9 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Long-Term Deferred Tax are $285.9 million (Q4 2025), $275.9 million (Q3 2025), and $253.1 million (Q2 2025).